Background. A Phase 1/11 study of an aggressive sixdrug chemotherapy regimen followed by the use of sequential hemibody radiation therapy as a possible noncross-resistant systemic treatment was undertaken for patients with extensive stage small cell lung cancer. Methods. The 20 enrolled patients re
Hemibody radiation, an active therapeutic modality for the management of patients with small cell lung cancer
β Scribed by R.C. Urtasun; A. Belch; D. Bodnar
- Publisher
- Elsevier Science
- Year
- 1983
- Tongue
- English
- Weight
- 418 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. The objective of this study was to assess the value of combinedβmodality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l
## BACKGROUND: The authors conducted a retrospective study to evaluate the effects of thoracic radiation therapy (TRT) for patients with extensive-stage small cell lung cancer (ED-SCLC). METHODS: Between January 2003 and December 2006, the records of 119 patients who were diagnosed with ED-SCLC (a
## Abstract In a retrospective analysis of 203 patients with small cell lung cancer (SCLC), we examined the prognostic value of cβkit expression on survival. Expression of cβkit was examined immunohistochemically in formalinβfixed, paraffinβembedded tissue sections. cβkit was observed in 87.7% of S